Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Correction for Kraft et al., "A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults".

Kraft CS, Parrott JS, Cornish NE, Rubinstein ML, Weissfeld AS, McNult P, Nachamkin I, Humphries RM, Kirn TJ, Dien Bard J, Lutgring JD, Gullett JC, Bittencourt CE, Benson S, Bobenchik AM, Sautter RL, Baselski V, Atlas MC, Marlowe EM, Miller NS, Fischer M, Richter SS, Gilligan P, Snyder JW.

Clin Microbiol Rev. 2019 Aug 28;32(4). pii: e00128-19. doi: 10.1128/CMR.00128-19. Print 2019 Sep 18. No abstract available.

2.

Whole Genome Sequencing to Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission Within and Between Regional Long-Term Acute Care Hospitals.

Han JH, Lapp Z, Bushman F, Lautenbach E, Goldstein EJC, Mattei L, Hofstaedter CE, Kim D, Nachamkin I, Garrigan C, Jain T, Bilker W, Wolford HM, Slayton RB, Wise J, Tolomeo P, Snitkin ES.

Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01622-19. doi: 10.1128/AAC.01622-19. [Epub ahead of print]

PMID:
31451495
3.

Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution.

Doan T, Hinterwirth A, Worden L, Arzika AM, Maliki R, Abdou A, Kane S, Zhong L, Cummings SL, Sakar S, Chen C, Cook C, Lebas E, Chow ED, Nachamkin I, Porco TC, Keenan JD, Lietman TM.

Nat Med. 2019 Sep;25(9):1370-1376. doi: 10.1038/s41591-019-0533-0. Epub 2019 Aug 12.

PMID:
31406349
4.

A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults.

Kraft CS, Parrott JS, Cornish NE, Rubinstein ML, Weissfeld AS, McNult P, Nachamkin I, Humphries RM, Kirn TJ, Dien Bard J, Lutgring JD, Gullett JC, Bittencourt CE, Benson S, Bobenchik AM, Sautter RL, Baselski V, Atlas MC, Marlowe EM, Miller NS, Fischer M, Richter SS, Gilligan P, Snyder JW.

Clin Microbiol Rev. 2019 May 29;32(3). pii: e00032-18. doi: 10.1128/CMR.00032-18. Print 2019 Jun 19. Erratum in: Clin Microbiol Rev. 2019 Aug 28;32(4):.

5.

A Clinical Prediction Tool for Extended-Spectrum Cephalosporin Resistance in Community-Onset Enterobacterales Urinary Tract Infection.

Weinstein EJ, Han JH, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Dankwa L, Wheeler M, Tolomeo P, Anesi JA; CDC Prevention Epicenters Program.

Open Forum Infect Dis. 2019 Mar 14;6(4):ofz164. doi: 10.1093/ofid/ofz164. eCollection 2019 Apr.

6.

The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.

Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler M, Tolomeo P, Han JH; CDC Prevention Epicenters Program.

BMC Infect Dis. 2019 Feb 14;19(1):163. doi: 10.1186/s12879-019-3804-y.

7.

The potential economic value of sputum culture use in patients with community-acquired pneumonia and healthcare-associated pneumonia.

Asti L, Bartsch SM, Umscheid CA, Hamilton K, Nachamkin I, Lee BY.

Clin Microbiol Infect. 2019 Aug;25(8):1038.e1-1038.e9. doi: 10.1016/j.cmi.2018.11.031. Epub 2018 Dec 24.

PMID:
30590113
8.

Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae.

Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler MK, Tolomeo P, Han JH; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1431-1435. doi: 10.1017/ice.2018.254. Epub 2018 Oct 30.

9.

Blood culture utilization at an academic hospital: Addressing a gap in benchmarking.

Chen AI, Bilker WB, Hamilton KW, O'Donnell JA, Nachamkin I.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1353-1359. doi: 10.1017/ice.2018.231. Epub 2018 Sep 28. Erratum in: Infect Control Hosp Epidemiol. 2018 Dec;39(12):1507-1509.

PMID:
30261936
10.

Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis.

Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program.

Crit Care Med. 2018 Jul;46(7):1106-1113. doi: 10.1097/CCM.0000000000003137.

11.

Multidrug and Mupirocin Resistance in Environmental Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates from Homes of People Diagnosed with Community-Onset MRSA Infection.

Shahbazian JH, Hahn PD, Ludwig S, Ferguson J, Baron P, Christ A, Spicer K, Tolomeo P, Torrie AM, Bilker WB, Cluzet VC, Hu B, Julian K, Nachamkin I, Rankin SC, Morris DO, Lautenbach E, Davis MF.

Appl Environ Microbiol. 2017 Oct 31;83(22). pii: e01369-17. doi: 10.1128/AEM.01369-17. Print 2017 Nov 15.

12.

Assessing Clinical Microbiology Practice Guidelines: American Society for Microbiology Ad Hoc Committee on Evidence-Based Laboratory Medicine Practice Guidelines Assessment.

Nachamkin I, Kirn TJ, Westblade LF, Humphries R.

J Clin Microbiol. 2017 Nov;55(11):3183-3193. doi: 10.1128/JCM.01124-17. Epub 2017 Aug 23. Review.

13.

Isolation of Campylobacter Species from Stool Samples by Use of a Filtration Method: Assessment from a United States-Based Population.

Nachamkin I, Nguyen P.

J Clin Microbiol. 2017 Jul;55(7):2204-2207. doi: 10.1128/JCM.00332-17. Epub 2017 May 3.

14.

Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial.

Sedrak MS, Myers JS, Small DS, Nachamkin I, Ziemba JB, Murray D, Kurtzman GW, Zhu J, Wang W, Mincarelli D, Danoski D, Wells BP, Berns JS, Brennan PJ, Hanson CW, Dine CJ, Patel MS.

JAMA Intern Med. 2017 Jul 1;177(7):939-945. doi: 10.1001/jamainternmed.2017.1144.

15.

A Novel Needle-Free Blood Draw Device for Sample Collection From Short Peripheral Catheters.

Cadacio C, Nachamkin I.

J Infus Nurs. 2017 May/Jun;40(3):156-162. doi: 10.1097/NAN.0000000000000222.

16.

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.

Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E; CDC prevention epicenters program.

Ann Clin Microbiol Antimicrob. 2017 Apr 8;16(1):25. doi: 10.1186/s12941-017-0202-4.

17.

Factors associated with persistent colonisation with methicillin-resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Nachamkin I, Coffin SE, Davis MF, Julian KG, Zaoutis TE, Metlay JP, Linkin DR, Tolomeo P, Wise JA, Bilker WB, Hu B, Lautenbach E; CDC PREVENTION EPICENTERS PROGRAM.

Epidemiol Infect. 2017 May;145(7):1409-1417. doi: 10.1017/S0950268817000012. Epub 2017 Feb 21.

PMID:
28219463
18.

Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.

Han JH, Garrigan C, Johnston B, Nachamkin I, Clabots C, Bilker WB, Santana E, Tolomeo P, Maslow J, Myers J, Carson L, Lautenbach E, Johnson JR; CDC Prevention Epicenters Program.

Diagn Microbiol Infect Dis. 2017 Mar;87(3):275-280. doi: 10.1016/j.diagmicrobio.2016.11.016. Epub 2016 Nov 28.

19.

Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples.

Garrigan C, Han J, Tolomeo P, Johnson KJ, Master SR, Lautenbach E, Nachamkin I.

Am J Transl Res. 2016 Oct 15;8(10):4362-4369. eCollection 2016.

20.

Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.

Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Wheeler M, Tolomeo P, Han JH.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1433-1439. Epub 2016 Sep 28.

21.

The Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Metlay JP, Nachamkin I, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, Tolomeo P, Wise JA, Wheeler MK, Hu B, Fishman NO, Royer D, Lautenbach E; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2016 Oct;37(10):1226-33. doi: 10.1017/ice.2016.138. Epub 2016 Jul 28.

PMID:
27465112
22.

Gastrointestinal Infections.

Alby K, Nachamkin I.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.DMIH2-0005-2015. Review.

PMID:
27337464
23.

A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study.

Downes KJ, Weiss SL, Gerber JS, Klieger SB, Fitzgerald JC, Balamuth F, Kubis SE, Tolomeo P, Bilker WB, Han X, Nachamkin I, Garrigan C, Han JH, Lautenbach E, Coffin SE; Centers for Disease Control and Prevention Epicenters Program.

J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):134-141. doi: 10.1093/jpids/piw023.

24.

Comparison of Culture-Based Methods for Identification of Colonization with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus in the Context of Cocolonization.

Davis MF, Hu B, Carroll KC, Bilker WB, Tolomeo P, Cluzet VC, Baron P, Ferguson JM, Morris DO, Rankin SC, Lautenbach E, Nachamkin I.

J Clin Microbiol. 2016 Jul;54(7):1907-1911. doi: 10.1128/JCM.00132-16. Epub 2016 Apr 27.

25.

Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.

Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program.

Diagn Microbiol Infect Dis. 2016 May;85(1):109-15. doi: 10.1016/j.diagmicrobio.2016.01.003. Epub 2016 Jan 8.

26.

Multicenter Evaluation of Clinical Diagnostic Methods for Detection and Isolation of Campylobacter spp. from Stool.

Fitzgerald C, Patrick M, Gonzalez A, Akin J, Polage CR, Wymore K, Gillim-Ross L, Xavier K, Sadlowski J, Monahan J, Hurd S, Dahlberg S, Jerris R, Watson R, Santovenia M, Mitchell D, Harrison C, Tobin-D'Angelo M, DeMartino M, Pentella M, Razeq J, Leonard C, Jung C, Achong-Bowe R, Evans Y, Jain D, Juni B, Leano F, Robinson T, Smith K, Gittelman RM, Garrigan C, Nachamkin I.

J Clin Microbiol. 2016 May;54(5):1209-15. doi: 10.1128/JCM.01925-15. Epub 2016 Mar 9.

27.

Occupational Exposure to Swine, Poultry, and Cattle and Antibody Biomarkers of Campylobacter jejuni Exposure and Autoimmune Peripheral Neuropathy.

Vegosen L, Breysse PN, Agnew J, Gray GC, Nachamkin I, Sheikh K, Kamel F, Silbergeld E.

PLoS One. 2015 Dec 4;10(12):e0143587. doi: 10.1371/journal.pone.0143587. eCollection 2015.

28.

Genome sequencing reveals strain dynamics of methicillin-resistant Staphylococcus aureus in the same household in the context of clinical disease in a person and a dog.

Davis MF, Misic AM, Morris DO, Moss JT, Tolomeo P, Beiting DP, Nachamkin I, Lautenbach E, Rankin SC.

Vet Microbiol. 2015 Nov 18;180(3-4):304-7. doi: 10.1016/j.vetmic.2015.09.007. Epub 2015 Sep 24.

29.

Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.

Han JH, Nachamkin I, Coffin SE, Gerber JS, Fuchs B, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Lautenbach E; Prevention Epicenters Program of the Centers for Disease Control and Prevention.

Antimicrob Agents Chemother. 2015 Oct;59(10):6494-500. doi: 10.1128/AAC.00958-15. Epub 2015 Aug 3.

30.

Appropriateness of expectorated sputum cultures in the hospital setting.

Sloan CE, Bernard S, Nachamkin I.

Diagn Microbiol Infect Dis. 2015 Sep;83(1):74-6. doi: 10.1016/j.diagmicrobio.2015.05.009. Epub 2015 May 21.

PMID:
26032431
31.

Risk factors for recurrent colonization with methicillin-resistant Staphylococcus aureus in community-dwelling adults and children.

Cluzet VC, Gerber JS, Nachamkin I, Metlay JP, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, Tolomeo P, Wise JA, Wheeler MK, Hu B, Fishman NO, Royer D, Lautenbach E.

Infect Control Hosp Epidemiol. 2015 Jul;36(7):786-93. doi: 10.1017/ice.2015.76. Epub 2015 Apr 14.

PMID:
25869756
32.

Risk factors for gyrA and parC mutations in Pseudomonas aeruginosa.

Cluzet VC, Lautenbach E, Nachamkin I, Cary MS, Fishman NO, Shih NN, Morales KH, Linkin DR.

Infect Control Hosp Epidemiol. 2015 Apr;36(4):387-93. doi: 10.1017/ice.2014.87.

PMID:
25782892
33.

The shared microbiota of humans and companion animals as evaluated from Staphylococcus carriage sites.

Misic AM, Davis MF, Tyldsley AS, Hodkinson BP, Tolomeo P, Hu B, Nachamkin I, Lautenbach E, Morris DO, Grice EA.

Microbiome. 2015 Jan 23;3:2. doi: 10.1186/s40168-014-0052-7. eCollection 2015.

34.

Duration of Colonization and Determinants of Earlier Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Nachamkin I, Metlay JP, Zaoutis TE, Davis MF, Julian KG, Royer D, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Mistry RD, Gavin LJ, Tolomeo P, Wise JA, Wheeler MK, Bilker WB, Han X, Hu B, Fishman NO, Lautenbach E.

Clin Infect Dis. 2015 May 15;60(10):1489-96. doi: 10.1093/cid/civ075. Epub 2015 Feb 3.

35.

Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection.

Bartsch SM, Umscheid CA, Nachamkin I, Hamilton K, Lee BY.

Clin Microbiol Infect. 2015 Jan;21(1):77.e1-9. doi: 10.1016/j.cmi.2014.07.002. Epub 2014 Oct 29.

36.

Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study.

Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E; CDC Prevention Epicenters Program.

J Antimicrob Chemother. 2015 May;70(5):1547-51. doi: 10.1093/jac/dku548. Epub 2015 Jan 27.

37.

Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli.

Han JH, Johnston B, Nachamkin I, Tolomeo P, Bilker WB, Mao X, Clabots C, Lautenbach E, Johnson JR; CDC Prevention Epicenters Program.

Antimicrob Agents Chemother. 2014 Nov;58(11):7003-6. doi: 10.1128/AAC.03256-14. Epub 2014 Sep 8.

38.

Distribution of Campylobacter jejuni capsular types, 2007-2012, Philadelphia, PA.

Garrigan C, Ettela A, Poly F, Guerry P, Nachamkin I.

Diagn Microbiol Infect Dis. 2014 Nov;80(3):204-6. doi: 10.1016/j.diagmicrobio.2014.08.002. Epub 2014 Aug 13.

PMID:
25192792
39.

Colonization of Cimex lectularius with methicillin-resistant Staphylococcus aureus.

Barbarin AM, Hu B, Nachamkin I, Levy MZ.

Environ Microbiol. 2014 May;16(5):1222-4. doi: 10.1111/1462-2920.12384. Epub 2014 Mar 3.

PMID:
24589308
40.

Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery.

Nelson DB, Hanlon A, Nachamkin I, Haggerty C, Mastrogiannis DS, Liu C, Fredricks DN.

Paediatr Perinat Epidemiol. 2014 Mar;28(2):88-96. doi: 10.1111/ppe.12106. Epub 2014 Jan 9.

41.

The effect of a hospital-wide urine culture screening intervention on the incidence of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species.

Han JH, Bilker WB, Nachamkin I, Zaoutis TE, Coffin SE, Linkin DR, Hu B, Tolomeo P, Fishman NO, Lautenbach E.

Infect Control Hosp Epidemiol. 2013 Nov;34(11):1160-6. doi: 10.1086/673453. Epub 2013 Sep 23.

42.

Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.

Han JH, Bilker WB, Nachamkin I, Tolomeo P, Mao X, Fishman NO, Lautenbach E.

Infect Control Hosp Epidemiol. 2013 Oct;34(10):1070-6. doi: 10.1086/673155. Epub 2013 Aug 23.

43.

Relationship of selected bacterial vaginosis-associated bacteria to Nugent score bacterial vaginosis among urban women early in pregnancy.

Nelson DB, Komaroff E, Nachamkin I, Haggerty CL, Dibble L, Mastrogiannis D, Liu C, Fredricks DN.

Sex Transm Dis. 2013 Sep;40(9):721-3. doi: 10.1097/OLQ.0000000000000001. Erratum in: Sex Transm Dis. 2014 Sep;41(9):570. David, Fredricks N [corrected to Fredricks, David N].

44.

Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones.

Han JH, Nachamkin I, Tolomeo P, Mao X, Bilker WB, Lautenbach E.

Diagn Microbiol Infect Dis. 2013 Aug;76(4):491-6. doi: 10.1016/j.diagmicrobio.2013.04.018. Epub 2013 May 27.

45.

Yield of methicillin-resistant Staphylococcus aureus on moist swabs versus dry swabs.

Codrington L, Kuncio D, Han J, Nachamkin I, Tolomeo P, Hu B, Lautenbach E.

Am J Infect Control. 2013 May;41(5):469-70. doi: 10.1016/j.ajic.2012.09.011. Epub 2013 Jan 20. No abstract available.

PMID:
23337302
46.

Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.

Greenblatt RM, Han JH, Nachamkin I, Tolomeo P, Lautenbach E.

Infect Control Hosp Epidemiol. 2013 Jan;34(1):40-8. doi: 10.1086/668780. Epub 2012 Nov 21. Review.

47.

Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients.

Han JH, Nachamkin I, Zaoutis TE, Coffin SE, Linkin DR, Fishman NO, Weiner MG, Hu B, Tolomeo P, Lautenbach E.

Infect Control Hosp Epidemiol. 2012 Dec;33(12):1242-5. doi: 10.1086/668443. Epub 2012 Oct 23.

48.

Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli.

Han JH, Nachamkin I, Tolomeo P, Mao X, Bilker WB, Lautenbach E.

J Infect Dis. 2012 Nov 15;206(10):1597-603. doi: 10.1093/infdis/jis567. Epub 2012 Sep 10.

49.

Fungal rhinosinusitis: a retrospective microbiologic and pathologic review of 400 patients at a single university medical center.

Montone KT, Livolsi VA, Feldman MD, Palmer J, Chiu AG, Lanza DC, Kennedy DW, Loevner LA, Nachamkin I.

Int J Otolaryngol. 2012;2012:684835. doi: 10.1155/2012/684835. Epub 2012 Feb 8.

50.

Culturing stool specimens for Campylobacter spp., Pennsylvania, USA.

M'ikanatha NM, Dettinger LA, Perry A, Rogers P, Reynolds SM, Nachamkin I.

Emerg Infect Dis. 2012 Mar;18(3):484-7. doi: 10.3201/eid1803.111266.

Supplemental Content

Loading ...
Support Center